Vaishali Pharma Limited
NSE:VAISHALI.NS
18.75 (INR) • At close November 5, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 180.798 | 323.96 | 278.954 | 125.656 | 134.227 | 268.098 | 199.979 | 131.591 | 96.644 | 215.575 | 221.792 | 198.614 | 81.385 | 177.277 | 212.672 | 100.299 | 34.563 | 200.298 | 101.747 | 103.85 | 181.975 | 277.256 | 277.256 | 98.199 | 98.199 | 224.35 | 224.35 | 114.47 | 114.47 |
Cost of Revenue
| 151.978 | 330.862 | 246.17 | 82.502 | 99.229 | 238.262 | 151.242 | 91.847 | 65.425 | 231.622 | 176.215 | 164.345 | 62.823 | 177.247 | 176.54 | 77.353 | 30.376 | 175.812 | 82.067 | 80.96 | 172.052 | 262.152 | 262.152 | 81.322 | 81.322 | 201.511 | 201.511 | 98.168 | 98.168 |
Gross Profit
| 28.82 | -6.902 | 32.784 | 43.154 | 34.998 | 29.836 | 48.737 | 39.744 | 31.219 | -16.047 | 45.577 | 34.269 | 18.562 | 0.03 | 36.132 | 22.946 | 4.187 | 24.486 | 19.68 | 22.89 | 9.923 | 15.104 | 15.104 | 16.877 | 16.877 | 22.84 | 22.84 | 16.303 | 16.303 |
Gross Profit Ratio
| 0.159 | -0.021 | 0.118 | 0.343 | 0.261 | 0.111 | 0.244 | 0.302 | 0.323 | -0.074 | 0.205 | 0.173 | 0.228 | 0 | 0.17 | 0.229 | 0.121 | 0.122 | 0.193 | 0.22 | 0.055 | 0.054 | 0.054 | 0.172 | 0.172 | 0.102 | 0.102 | 0.142 | 0.142 |
Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 5.995 | 0 | 0 | 0 | 6.806 | 0 | 0 | 0 | 23.349 | 0 | 0 | 0 | 41.616 | 0 | 0 | 0 | 4.978 | 4.978 | 0 | 0 | 6.727 | 6.727 | 0 | 0 |
Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 5.292 | 0 | 0 | 0 | 0.86 | 0 | 0 | 0 | 0.663 | 0 | 0 | 0 | 2.1 | 0 | 0 | 0 | 1.006 | 1.006 | 0 | 0 | 2.179 | 2.179 | 0 | 0 |
SG&A
| 6.572 | 62.31 | 4.498 | 10.702 | 5.393 | 11.287 | 8.764 | 8.356 | 9.342 | 7.666 | 16.768 | 6.236 | 2.986 | 24.012 | 4.529 | 4.49 | 4.561 | 43.716 | 3.057 | 6.625 | 3.361 | 5.984 | 5.984 | 7.22 | 7.22 | 8.907 | 8.907 | 5.003 | 5.003 |
Other Expenses
| 4.245 | 0 | 4.697 | 2.978 | 3.607 | 5.296 | 5.294 | 7.354 | 4.343 | -16.23 | 4.074 | 3.649 | 5.667 | -10.834 | 3.111 | 3.73 | 5.417 | 0 | 0 | 8.499 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Expenses
| 6.572 | 62.31 | 4.498 | 17.822 | 13.11 | 23.552 | 14.378 | 15.237 | 10.118 | -27.991 | 22.736 | 13.127 | 6.884 | -3.6 | 10.216 | 11.131 | 5.14 | -0.799 | 10.587 | 17.482 | 4.068 | 11.573 | 11.573 | 7.691 | 7.691 | 18.27 | 18.27 | 7.52 | 7.52 |
Operating Income
| 22.248 | -69.212 | 28.286 | 28.31 | 21.888 | 11.58 | 39.653 | 31.861 | 25.444 | 13.122 | 26.915 | 24.791 | 17.355 | 9.363 | 29.027 | 15.545 | 4.474 | 38.96 | 9.093 | 13.906 | 5.77 | 5.06 | 5.06 | 4 | 4 | 8.854 | 8.854 | 3.842 | 3.842 |
Operating Income Ratio
| 0.123 | -0.214 | 0.101 | 0.225 | 0.163 | 0.043 | 0.198 | 0.242 | 0.263 | 0.061 | 0.121 | 0.125 | 0.213 | 0.053 | 0.136 | 0.155 | 0.129 | 0.195 | 0.089 | 0.134 | 0.032 | 0.018 | 0.018 | 0.041 | 0.041 | 0.039 | 0.039 | 0.034 | 0.034 |
Total Other Income Expenses Net
| 0.454 | 5.048 | 0.349 | -4.711 | -0.697 | -5.359 | -4.159 | -5.273 | -5.294 | -6.781 | -5.484 | -6.105 | -6.53 | -29.031 | -5.863 | -5.13 | -4.441 | -49.65 | -5.717 | -6.087 | -5.69 | -1.54 | -1.54 | -1.858 | -1.858 | -3.649 | -3.649 | -2.319 | -2.319 |
Income Before Tax
| 22.702 | -64.164 | 28.635 | 23.599 | 21.191 | 6.221 | 35.494 | 26.588 | 20.15 | 6.341 | 21.431 | 18.686 | 10.825 | -19.668 | 23.164 | 10.415 | 0.033 | -10.69 | 3.376 | 7.819 | 0.08 | 3.52 | 3.52 | 2.143 | 2.143 | 5.204 | 5.204 | 1.523 | 1.523 |
Income Before Tax Ratio
| 0.126 | -0.198 | 0.103 | 0.188 | 0.158 | 0.023 | 0.177 | 0.202 | 0.208 | 0.029 | 0.097 | 0.094 | 0.133 | -0.111 | 0.109 | 0.104 | 0.001 | -0.053 | 0.033 | 0.075 | 0 | 0.013 | 0.013 | 0.022 | 0.022 | 0.023 | 0.023 | 0.013 | 0.013 |
Income Tax Expense
| 5.712 | -17.339 | 7.516 | 6.563 | 5.332 | 1.866 | 8.874 | 6.647 | 5.037 | 4.312 | 5.359 | 4.671 | 2.706 | -5.182 | 6.049 | 2.708 | 0.01 | -2.522 | 0.932 | 2.033 | 0.021 | 1.505 | 1.505 | 0.589 | 0.589 | 2.299 | 2.299 | 0.441 | 0.441 |
Net Income
| 16.99 | -46.825 | 21.119 | 17.036 | 15.859 | 4.361 | 26.62 | 19.941 | 15.113 | 2.028 | 16.072 | 14.015 | 8.119 | -14.485 | 17.215 | 7.707 | 0.033 | -8.168 | 2.444 | 5.786 | 0.059 | 2.014 | 2.014 | 1.554 | 1.554 | 2.905 | 2.905 | 1.083 | 1.083 |
Net Income Ratio
| 0.094 | -0.145 | 0.076 | 0.136 | 0.118 | 0.016 | 0.133 | 0.152 | 0.156 | 0.009 | 0.072 | 0.071 | 0.1 | -0.082 | 0.081 | 0.077 | 0.001 | -0.041 | 0.024 | 0.056 | 0 | 0.007 | 0.007 | 0.016 | 0.016 | 0.013 | 0.013 | 0.009 | 0.009 |
EPS
| 1.4 | -4.37 | 1.99 | 1.61 | 1.5 | 0.41 | 2.52 | 1.89 | 1.43 | 0.19 | 1.52 | 1.33 | 0.77 | -1.37 | 1.63 | 0.73 | 0.01 | -0.76 | 0.23 | 0.55 | 0.01 | 0.19 | 0.19 | 0.15 | 0.15 | 0.27 | 0.27 | 0.14 | 0.14 |
EPS Diluted
| 1.38 | -4.37 | 1.89 | 1.52 | 1.41 | 0.06 | 2.52 | 1.89 | 1.43 | 0.19 | 1.52 | 1.33 | 0.77 | -1.37 | 1.63 | 0.73 | 0.01 | -0.76 | 0.23 | 0.55 | 0.01 | 0.19 | 0.19 | 0.15 | 0.15 | 0.27 | 0.27 | 0.14 | 0.14 |
EBITDA
| 23.44 | -67.807 | 29.528 | 29.546 | 26.693 | 13.101 | 40.848 | 33.306 | 26.327 | 14.621 | 27.941 | 25.81 | 18.374 | 10.492 | 30.087 | 16.599 | 5.51 | 42.254 | 9.693 | 14.893 | 6.434 | 5.724 | 5.681 | 4.622 | 4.622 | 9.475 | 9.52 | 4.508 | 4.508 |
EBITDA Ratio
| 0.13 | -0.209 | 0.106 | 0.235 | 0.199 | 0.049 | 0.204 | 0.253 | 0.272 | 0.068 | 0.126 | 0.13 | 0.226 | 0.059 | 0.141 | 0.165 | 0.159 | 0.211 | 0.095 | 0.143 | 0.035 | 0.021 | 0.02 | 0.047 | 0.047 | 0.042 | 0.042 | 0.039 | 0.039 |